tradingkey.logo

Gilead Finalizes Agreement With Global Fund To Accelerate Access To Lenacapavir

ReutersJul 9, 2025 2:33 PM

- Gilead Sciences Inc GILD.O:

  • GILEAD SCIENCES: AGREEMENT WITH GLOBAL FUND TO ACCELERATE ACCESS TO LENACAPAVIR FOR HIV PREVENTION IN LOW-INCOME COUNTRIES

  • GILEAD SCIENCES: TO PROVIDE LENACAPAVIR TO 2 MILLION PEOPLE OVER 3 YEARS IN COUNTRIES SUPPORTED BY GLOBAL FUND, AT NO PROFIT TO GILEAD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI